Brain biopsies on 'vulnerable' patients at Mount Sinai set off alarm bells at FDA

A STAT examination of the Living Brain Project raises questions about how such a sensitive research study ballooned exponentially.

May 1, 2024 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | Brain biopsies on 'vulnerable' patients at Mount Sinai set off alarm bells at FDA, documents show A STAT examination of the Living Brain Project raises questions about how such a sensitive research study ballooned exponentially. By Katherine Eban STAT+ | Lawmakers grill UnitedHealth CEO on Change cyberattack: 'Your company let the country down' UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a "single attack [that] kicked off a cascading series of crises." By Brittany Trang Pasteurization inactivates H5N1 bird flu in milk, new FDA and academic studies confirm The results confirmed earlier testing and add weight to the FDA's conclusion that pasteurized milk products are safe from bird flu virus. By Megan Molteni Gareth Cattermole/Getty Images for Disney Opinion: Colorectal cancer is increasing among young people. It's time to boost research on it Young people like Chadwick Boseman are dying of colorectal cancer. More and better research could help reverse that terrible trend. By Simone Ledward-Boseman After private equity firms gobbled up wheelchair makers, users pay the price in long repair times Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired. By Timmy Broderick Lawmakers, as part of 'lab leak' Covid inquiry, press to bar EcoHealth from federal research funds A House subcommittee investigating the "lab leak" theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan. By Sarah Owermohle Eric Gay/AP Exercise is good for health — but why? A study in rats offers insight A research consortium conducting a 10-year study of exercise biology released its first paper, working to map exercise benefits on the molecular level in rats. By Annalisa Merelli STAT+ | CVS went hard after Medicare Advantage patients, now it's retreating CVS Health misses first quarter projections and lowers full-year outlook, citing medical cost hikes with Medicare Advantage patients. Stock price slides. By Tara Bannow STAT+ | To regrow blood vessels after heart attack, a little transplant of mitochondria goes a long way in mice A heart attack or poor circulation from diabetes can wreak damage on blood vessels. Scientists want to use mitochondria to jump-start repairs. By Elizabeth Cooney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser